Joshua Zeidner: Important results from ENHANCE-3 by Naval Daver

Joshua Zeidner, Associate Professor at UNC Lineberger, shared on X:

“Disappointing but important results from ENHANCE-3 by Naval Daver. We need to learn from these negative trials to design the optimal studies, protocols, and dosing schedules in the future. Still unclear why there were more infection-related deaths with Magrolimab. ”

Source: Joshua Zeidner/X